AstraZeneca: Hungary to Follow EMA Advice, Chief Medical Officer says
Hungary will follow the European drug regulator’s advice on how to proceed with the use of AstraZeneca’s Covid-19 jab, the chief medical officer told an online press briefing on Wednesday.
Cecília Müller noted that several countries have either suspended the use of the British-Swedish drugmaker’s vaccine or are limiting its use to certain age groups after reports of some of its recipients experiencing rare blood clots. She also noted that on Tuesday a senior official for the European Medicines Agency (EMA) said there was a clear link between the vaccine and rare blood clots in the brain, although its causes were unknown.